Page 137 - 2021年17期

抗肿瘤作用的影响及其机制[J].中国肺癌杂志，2015，18 Prev，2015，16（6）：2129-2144.
（8）：481-486. [22] TONG N，ZHANG J，CHEN Y，et al. Berberine sensitizes
[ 9 ] ZHU T，LI LL，XIAO G F，et al. Berberine increases doxo- mutliple human cancer cells to the anticancer effects of
rubicin sensitivity by suppressing STAT3 in lung can- doxorubicin in vitro[J]. Oncol Lett，2012，3（6）：1263-
cer[J]. Am J Chin Med，2015，43（7）：1487-1502. 1267.
[10] 石金凤，李杰，杨晓琴，等.中药活性成分协同化疗药物的 [23] MITTAL A，TABASUM S，SINGH R P. Berberine in com-
纳米共载体系联合抗肿瘤现状分析[J].药学学报，2019， bination with doxorubicin suppresses growth of murine
54（2）：258-268. melanoma B16F10 cells in culture and xenograft[J].
[11] HE C，TANG Z，TIAN H，et al. Co-delivery of chemothe- Phytomedicine，2014，21（3）：340-347.
rapeutics and proteins for synergistic therapy[J]. Adv [24] DU J，SUN Y，LU Y Y，et al. Berberine and evodiamine
Drug Deliv Rev，2016，98：64-76. act synergistically against human breast cancer MCF-7
[12] 邢玉桂.吴茱萸碱脂质体在大鼠体内的药动学及小鼠体 cells by inducing cell cycle arrest and apoptosis[J]. Anti-
内的组织分布研究[J].中国药房，2016，27（16）：2236- cancer Res，2017，37（11）：6141-6151.
2239. [25] LIN S R，CHANG C H，HSU CF，et al. Natural com-
[13] LI Y J，LEI Y H，YAO N，et al. Autophagy and multidrug pounds as potential adjuvants to cancer therapy：preclini-
resistance in cancer[J]. Chin J Cancer，2017，6（1）：52. cal evidence[J]. Br J Pharmacol，2020，177（6）：1409-
[14] BLOCK K I，GYLLENHAAL C，LOWE L，et al. A broad- 1423.
spectrum integrative design for cancer prevention and the- [26] GUAN X，ZHENG X，VONG C T，et al. Combined ef-
rapy：the challenge ahead[J]. Semin Cancer Biol，2015， fects of berberine and evodiamine on colorectal cancer
35：S1-S4. cells and cardiomyocytes in vitro[J]. Eur J Pharmacol，
[15] CAMPONE M，JUIN P，ANDRE F，et al. Resistance to 2020，875：173031.
HER2 inhibitors：is addition better than substitution? Ra- [27] 宋霞，程滨，刘谋治，等.小檗碱对多柔比星的增效减毒作
tionale for the hypothetical concept of drug sedimenta- 用及其机制研究进展[J].现代药物与临床，2014，29（3）：
tion[J]. Crit Rev Oncol Hematol，2011，78（3）：195-205. 306-311.
[16] ZHANG R，QIAO H，CHEN S，et al. Berberine reverses [28] ZHAO X Y，ZHANG J，TONG N N，et al. Berberine atte-
lapatinib resistance of HER2-positive breast cancer cells nuates doxorubicin-induced cardiotoxicity in mice[J]. Int
by increasing the level of ROS[J]. Cancer Biol Ther， Med Res，2011，39（5）：1720-1727.
2016，17（9）：925-934. [29] WU Y Z，ZHANG L，WU Z X，et al. Berberine amelio-
[17] MANOOCHEHRI K H，AFSHAR S，NAJAFI R，et al. rates doxorubicin-induced cardiotoxicity via a SIRT1/
Hypoxia：a double-edged sword in cancer therapy[J]. Can- p66Shc-mediated pathway[J]. Oxid Med Cell Longev，
cer Invest，2016，34（10）：536-545. 2019，2019：2150394.
[18] PAN Y，SHAO D，ZHAO Y，et al. Berberine reverses hy- [30] CHEN X，ZHANG Y，ZHU Z，et al. Protective effect of
poxia-induced chemoresistance in breast cancer through berberine on doxorubicin induced acute hepatorenal toxici-
the inhibition of AMPK-HIF-1α[J]. Int J Biol Sci，2017，13 ty in rats[J]. Mol Med Rep，2016，13（5）：3953-3960.
（6）：794-803. [31] GUPTA P，JANI K A，YANG D H，et al. Revisiting the
[19] GALSKI H，OVED-GELBER T，SIMANOVSKY M，et al. role of nanoparticles as modulators of drug resistance and
P-glycoprotein-dependent resistance of cancer cells to- metabolism in cancer[J]. Expert Opin Drug Metab Toxicol，
ward the extrinsic TRAIL apoptosis signaling pathway[J]. 2016，12（3）：281-289.
Biochem Pharmacol，2013，86（5）：584-596. [32] ZUNUNI V S，SALEHI R，DAVARAN S，et al. Lipo-
[20] REFAAT A，ABDELHAMED S，YAGITA H，et al. Berbe- some-based drug co-delivery systems in cancer cells[J].
rine enhances tumor necrosis factor-related apoptosis- Mater Sci Eng C Mater Biol Appl，2017，71：1327-1341.
inducing ligand-mediated apoptosis in breast cancer[J]. [33] YU G，NING Q，MO Z，et al. Intelligent polymeric mi-
Oncol Lett，2013，6（3）：840-844. celles for multidrug co-delivery and cancer therapy[J].
[21] GOLDAR S，KHANIANI M S，DERAKHSHAN S M， Artif Cells Nanomed Biotechnol，2019，47（1）：1476-1487.
et al. Molecular mechanisms of apoptosis and roles in can- [34] YANG Z，ZHAO L，WANG X，et al. Ratiometric delivery
cer development and treatment[J]. Asian Pac J Cancer of mitoxantrone and berberine co-encapsulated liposomes

中国药房 2021年第32卷第17期 China Pharmacy 2021 Vol. 32 No. 17 ·2175 ·